In patients with COVID-19, the total number of NK and CTLs are decreased which is in parallel with exhaustion of their function and upregulation of NK inhibitory receptor CD94/NK group 2 member A (NKG2A) (81). The gene discussed is KLRC1; the disease is COVID-19.